Hamaguchi Y, Yoshimura Y, Horii M, Fushida N, et al. Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti-topoisomerase I antibody. J Dermatol 2024;51:62-69.
PMID: 37864453